DVA News and Press, DaVita Inc. From 12/11/22

Summary Healthcare stocks have been strong recently and for the year amid heightened volatility. One healthcare provider has dealt with an unfavorable SCOTUS ruling and a big EPS miss in recent months. With impressive free cash flow expected offering upside potential, risks are seen...

Summary Berkshire Hathaway's 13F stock portfolio value decreased from ~$300B to ~$296B. Their largest three holdings are at ~60% of the entire portfolio. Berkshire Hathaway added Taiwan Semi and increased Occidental Petroleum and Paramount Global while decreasing US Bancorp an...

DaVita Clinical Research Showcases Chronic Kidney Disease and Rare Disease Network, Presents New Research Findings at Kidney Week 2022 PR Newswire This year's research centered on advancements in kidney transplantation and equity in patient care DaVita addresse...

Shares of DaVita HealthCare Partners ( NYSE: DVA ) closed Friday down ~27% after Q3 2022 financial results missed on the top and bottom lines and it reduced its 2022 outlook. DaVita ( DVA ) was hit in the quarter by lower volume due to COVID-19 and increases in...

DaVita Inc. (DVA) Q3 2022 Earnings Conference Call October 28, 2022, 08:30 AM ET Company Participants Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Andrew Mok - UBS Kevin Fischbeck - Ba...

Wall Street continued to wade through the incoming flood of earnings news during Friday's midday action. The latest group of reports included rally-inspiring figures from Pinterest ( PINS ), T-Mobile ( TMUS ) and VeriSign ( VRSN ). However, not every quarterly update trigger...

Image source: The Motley Fool. DaVita (NYSE: DVA) Q3 2022 Earnings Call Oct 28, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: DaVita (DVA) Q3 2022 Earnings Call Transcript

It's been a tough market environment for investors, with big whipsaws in both directions reflecting the massive uncertainty companies face. Uncertainty once again showed up in the relative movements of different stock market indexes Friday morning. The Dow Jones Industrial Average (DJ...

Dialysis services provider DaVita ( NYSE: DVA ) fell short of Street forecasts with its Q3 2022 financials on Friday amid worse-than-expected COVID-driven volume trends and unfavorable labor market conditions. "Like others in the healthcare community, negative volume trends ...

DaVita HealthCare Partners press release ( NYSE: DVA ): Q3 Non-GAAP EPS of $1.45 misses by $0.32 . Revenue of $2.95B (+0.3% Y/Y) misses by $30M . For FY2022, Adjusted diluted EPS to be in the range of $6.20 to $6.70 vs. prior view of $7.50 to $8.50 and consensu...